Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss

Yukmijihwang-tang (YJ) has been used to treat diabetes mellitus, renal disorders, and cognitive impairment in traditional medicine. This study aimed to evaluate the anti-osteoporotic effect of YJ on ovariectomy (OVX)-induced bone loss in a rat and receptor activator of nuclear factor kappa-B ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sang-Yong, Kim, Yun-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706552/
https://www.ncbi.nlm.nih.gov/pubmed/34946658
http://dx.doi.org/10.3390/molecules26247579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706552/
https://www.ncbi.nlm.nih.gov/pubmed/34946658
http://dx.doi.org/10.3390/molecules26247579

Ejemplares similares